Wealth Quarterback LLC Purchases Shares of 5,003 DaVita Inc. (NYSE:DVA)

Wealth Quarterback LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 5,003 shares of the company's stock, valued at approximately $765,000.

A number of other large investors have also bought and sold shares of DVA. United Capital Financial Advisors LLC increased its position in shares of DaVita by 2.6% in the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after acquiring an additional 62 shares during the last quarter. Freedom Investment Management Inc. grew its holdings in DaVita by 3.6% during the fourth quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock worth $268,000 after purchasing an additional 62 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock worth $531,000 after purchasing an additional 69 shares during the period. UMB Bank n.a. grew its holdings in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares during the period. Finally, Exchange Traded Concepts LLC grew its holdings in DaVita by 8.9% during the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after purchasing an additional 79 shares during the period. 90.12% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DVA has been the subject of a number of research analyst reports. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Truist Financial reduced their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $164.50.

DaVita Price Performance

DVA traded up $4.60 during trading on Wednesday, hitting $150.65. 508,445 shares of the stock traded hands, compared to its average volume of 811,336. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60. The company has a market cap of $11.37 billion, a price-to-earnings ratio of 14.91, a PEG ratio of 0.96 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The business has a 50 day moving average price of $140.06 and a 200 day moving average price of $148.45.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The company's revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.26 earnings per share. Equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.